awmsg logo



interferon beta-1a (Rebif®)


Reference No. 1510

Publication date:
19/06/2012


Appraisal information

interferon beta-1a (Rebif®) solution for injection


Company: Merck Serono Ltd
BNF category: Malignant disease and immunosupression
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Superseded
Advice No: Not available
Ratification by Welsh Government: 19/06/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

AWMSG ADVICE SUPERSEDED BY NICE GUIDANCE (TA527) NICE GUIDANCE ISSUED MAY 2018 (Refer to NICE website for full guidance on NICE recommendations, including any specific restrictions on the use of the technology)
Statement of Advice (SOA)
Download